Medpace Holdings, Inc. (MEDP)
599.47
+1.39
(+0.23%)
USD |
NASDAQ |
Oct 02, 16:00
599.50
+0.03
(+0.01%)
After-Hours: 20:00
Medpace Holdings Max Drawdown (5Y) : 42.87% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 42.87% |
| August 31, 2026 | 42.87% |
| July 31, 2026 | 42.87% |
| June 30, 2026 | 42.87% |
| May 31, 2026 | 42.87% |
| April 30, 2026 | 42.87% |
| March 31, 2026 | 42.87% |
| February 28, 2026 | 42.87% |
| January 31, 2026 | 42.87% |
| December 31, 2025 | 42.87% |
| November 30, 2025 | 42.87% |
| October 31, 2025 | 42.87% |
| September 30, 2025 | 42.87% |
| August 31, 2025 | 42.87% |
| July 31, 2025 | 42.87% |
| June 30, 2025 | 42.87% |
| May 31, 2025 | 42.87% |
| April 30, 2025 | 42.87% |
| March 31, 2025 | 42.87% |
| February 28, 2025 | 42.87% |
| January 31, 2025 | 42.87% |
| December 31, 2024 | 42.87% |
| November 30, 2024 | 42.87% |
| October 31, 2024 | 42.87% |
| September 30, 2024 | 42.87% |
| Date | Value |
|---|---|
| August 31, 2024 | 42.87% |
| July 31, 2024 | 42.87% |
| June 30, 2024 | 42.87% |
| May 31, 2024 | 42.87% |
| April 30, 2024 | 42.87% |
| March 31, 2024 | 42.87% |
| February 29, 2024 | 42.87% |
| January 31, 2024 | 42.87% |
| December 31, 2023 | 42.87% |
| November 30, 2023 | 42.87% |
| October 31, 2023 | 42.87% |
| September 30, 2023 | 42.87% |
| August 31, 2023 | 42.87% |
| July 31, 2023 | 42.87% |
| June 30, 2023 | 42.87% |
| May 31, 2023 | 42.87% |
| April 30, 2023 | 42.87% |
| March 31, 2023 | 42.87% |
| February 28, 2023 | 42.87% |
| January 31, 2023 | 42.87% |
| December 31, 2022 | 42.87% |
| November 30, 2022 | 42.87% |
| October 31, 2022 | 42.87% |
| September 30, 2022 | 42.87% |
| August 31, 2022 | 42.87% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| IQVIA Holdings, Inc. | 51.52% |
| Charles River Laboratories International, Inc. | 78.23% |
| Avantor, Inc. | 83.16% |
| Champions Oncology, Inc. | 78.53% |
| Personalis, Inc. | 98.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 11.37 |
| Beta (5Y) | 1.179 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 44.35% |
| Historical Sharpe Ratio (5Y) | 0.5224 |
| Historical Sortino (5Y) | 1.032 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.43% |